ZIVO 📈 Zivo Bioscience - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98978N2009

ZIVO: Algae, Bioactive Ingredients, Animal Feed, Human Supplements, Medical Food

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan. Web URL: https://www.zivobioscience.com

Additional Sources for ZIVO Stock

ZIVO Stock Overview

Market Cap in USD 73m
Sector Healthcare
Industry Biotechnology
GiC Sub-Industry Personal Care Products
IPO / Inception 2012-09-24

ZIVO Stock Ratings

Growth 5y 75.0%
Fundamental -
Dividend -
Rel. Strength Industry 6527
Analysts 3/5
Fair Price Momentum 21.73 USD
Fair Price DCF -

ZIVO Dividends

No Dividends Paid

ZIVO Growth Ratios

Growth Correlation 3m 32%
Growth Correlation 12m 88.6%
Growth Correlation 5y 37.3%
CAGR 5y 85.95%
CAGR/Mean DD 5y 2.05
Sharpe Ratio 12m 1.71
Alpha 339.78
Beta 2.56
Volatility %
Current Volume 2.9k
Average Volume 20d 1.1k
What is the price of ZIVO stocks?
As of December 22, 2024, the stock is trading at USD 19.00 with a total of 2,900 shares traded.
Over the past week, the price has changed by -18.41%, over one month by -23.18%, over three months by +17.56% and over the past year by +1084.33%.
Is Zivo Bioscience a good stock to buy?
Yes. Based on ValueRay Analyses, Zivo Bioscience (NASDAQ:ZIVO) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 74.95 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZIVO as of December 2024 is 21.73. This means that ZIVO is currently undervalued and has a potential upside of +14.37% (Margin of Safety).
Is ZIVO a buy, sell or hold?
Zivo Bioscience has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold ZIVO.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ZIVO stock price target?
According to ValueRays Forecast Model, ZIVO Zivo Bioscience will be worth about 25.4 in December 2025. The stock is currently trading at 19.00. This means that the stock has a potential upside of +33.47%.
Issuer Forecast Upside
Wallstreet Target Price 12 -36.8%
Analysts Target Price 6 -68.4%
ValueRay Target Price 25.4 33.5%